View Document Preview and Link
Document Date: 2014-07-30 15:57:16 Open Document File Size: 318,04 KB Share Result on Facebook
City London / / Company Merck & Co. Inc. / GlaxoSmithKline / Family Medicine Group / Merck / Cox / Gardasil® Merck & Co. / Glaxosmithkline plc / / Country United States / United Kingdom / / Currency USD / / Event FDA Phase / / Facility Whitehouse Station / / MedicalCondition hepatitis a / cervical cancers / HPV-related cervical disease / genital herpes / incident and persistent HPV infection / significant disease / chronic / persistent infection / Human Papilloma Virus Vaccination Pre-adolescent Female HPV Infection / flat warts / recurrent respiratory papillomatosis / herpes / Condylomata acuminata / HPV infection / genital warts / Most HPV infections / CIN / prevalent HPV infections / infections / head cancers / HPV disease / genital HPV infection / adenocarcinoma / also anogenital disease / cancers / adenocarcinomas / Cancer / cervical intraepithelial neoplasia grade / disease / HPV-related disease / chronic and persistent infection / HPV / Unilaterally Reduce Endo/Ectocervical Disease / cervical cancer / persistent HPV infection / HPV infections / obstructive papillomas / plantar warts / cervical intraepithelial neoplasia / human papilloma virus / persistent infection / sexually transmitted infections / neck cancers / anogenital cancers / infection / gonorrhea / / MedicalTreatment Immunization / / Organization Family Medicine Foundation / SUNY at Buffalo / Society of Teachers / Immunization Education Society of Teachers of Family Medicine CLINICAL SCENARIO SERIES ON IMMUNIZATION Human Papilloma Virus Vaccination Pre-adolescent Female Written / FACE Department of Family Medicine School of Medicine & Biomedical Sciences / FDA / International Agency for Research / / Person Abigail / Female / Diaz / Martin C. Mahoney / Schroeder / / Position physician / / Product HPV-16 / Cervarix™ / HPV / / Technology antibodies / / SocialTag